BONE DISEASE IN PRIMARY HYPERCALCIURIA

REFERENCES

• Albright F, Henneman P, Benedict P H, Forbes A P. Idiopathic hypercalciuria: a preliminary report. Proc R Soc Med 1953; 46: 1077–1081, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Hodgkinson A, Pyrah L N. The urinary excretion of calcium and inorganic phosphate in 344 patients with calcium stone of renal origin. Br J Surg 1958; 46: 10–18, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Smith L H, VanDenBerg Cj, Wilson D M. Nutrition and urolithiasis. N Engl J Med 1980; 98: 87–89
   Google Scholar
• Pak C Y. Medical management of nephrolithiasis. J Urol 1982; 128: 1157–1164, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Pak C Y, Ohata M, Lawrence E C, Synder W. The hypercalciurias: causes, parathyroid functions, and diagnostic criteria. J Clin Invest 1974; 54: 387–400, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Heaney R P, Recker R R, Ryan R A. Urinary calcium in perimenopausal women: normative values. Osteoporos Int 1999; 9: 13–18, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Kerstetter J E, O'Brian K O, Insogna K L. Low protein intake: the impact on calcium and bone homeostasis in humans. J Nutr 2003; 133: 855S–861S, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Nordin B E, Need A G, Morris H A, Horowitz M. The nature and significance of the relationship between urinary sodium and urinary calcium in women. J Nutr 1993; 123: 1615–1622, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hegsted M, Schuette S A, Zemel M B, Linkswiler H M. Urinary calcium and calcium balance in young men as affected by level of protein and phosphorus intake. J Nutr 1981; 111: 553–562, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Zemel M B. Calcium utilization: effect of varying level and source of dietary protein. Am J Clin Nutr 1988; 48: 880–883, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Kerstetter J E, O'Brien K O, Insogna K L. Dietary protein, calcium metabolism, and skeletal homeostasis revisited. Am J Clin Nutr 2003; 78: 584S–592S, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Pak C Y, Britton F, Peterson R, Ward D, Northcott C, Breslau N, MacGuire J, Nicar M, Norman D A, Peters P. Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria. Am J Med 1980; 69: 19–30, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Vezzoli G, Tanini A, Ferrucci L, Soldati L, Bianchin C, Franceschelli F, Malentacchi C, Porfirio B, Adamo D, Terranegra A, Falchetti A, Cusi D, Bianchi G, Brandi M L. Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. J Am Soc Nephrol 2002; 13: 2517–2523, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Broadus A E, Insogna K L, Lang R, Ellison A F, Dreyer B E. Evidence for disordered control of 1,25-dihydroxyvitamin D production in absorptive hypercalciuria. N Engl J Med 1984; 311: 73–80, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Li X Q, Tembe V, Horwitz G M, Bushinsky D A, Favus M J. Increased intestinal vitamin D receptor in genetic hypercalciuric rats. A cause of intestinal calcium hyperabsorption. J Clin Invest 1993; 91: 661–667, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Zerwekh J E, Reed B Y, Heller H J, Gonzalez G B, Haussler M R, Pak C Y. Normal vitamin D receptor concentration and responsiveness to 1, 25-dihydroxyvitamin D3 in skin fibroblasts from patients with absorptive hypercalciuria. Miner Electrolyte Metab 1998; 24: 307–313, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Prié D, Ravery V, Boccon-Gibod L, Friedlander G. Frequency of renal phosphate leak among patients with calcium nephrolithiasis. Kidney Int 2001; 60: 272–276, [CROSSREF]
   Google Scholar
• Bushinsky D A. Genetic hypercalciuric stone-forming rats. Curr Opin Nephrol Hypertens 1999; 8: 479–88, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Bataille P, Fardellone P, Ghazali A, Cayrolle G, Hottelart C, Achard J M, Fournier A. Pathophysiology and treatment of idiopathic hypercalciuria. Curr Opin Rheumatol 1998; 10: 373–388, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Levy F L, Adams-Huet B, Pak C YC. Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med 1998; 98: 50–59, [CROSSREF]
   Google Scholar
• Weisinger J R. New insights in the pathogenesis of idiopathic hypercalciuria; the role of bone. Kidney Int 1996; 49: 1507–1518, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Lawoyin S, Sismilich S, Browne R, Pak C Y. Bone mineral content in patients with calcium urolithiasis. Metabolism 1979; 28: 1250–1254, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Fuss M, Gillet C, Simon J, Vandewalle J C, Schoutens A, Bergmann P. Bone mineral content in idiopathic renal stone disease and in primary hyperparathyroidism. Eur Urol 1983; 9: 32–34, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Pacifici R, Rothstein M, Rifas L, Lau K H, Baylink D J, Avioli L V, Hruska K. Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. J Clin Endocrinol Metab 1990; 71: 138–145, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Bataille P, Achard J M, Fournier A, Boudailliez B, Westeel P F, El Esper N, Bergot C, Jans I, Lalau J D, Petit J, Henon G, Laval Jeantet M A, Bouillon R, Sebert J L. Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers. Kidney Int 1991; 39: 1193–1205, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Borghi L, Meschi T, Guerra A, Maninetti L, Pedrazzoni M, Marcato A, Vescovi P, Novarini A. Vertebral mineral content in diet-dependent and diet-independent hypercalciuria. J Urol 1991; 146: 1334–1338, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Pietschmann F, Breslau N A, Pak C Y. Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Miner Res 1992; 7: 1383–1388, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Jaeger P, Lippuner K, Casez J P, Hess B, Ackermann D, Hug C. Low bone mass in idiopathic renal stone formers: magnitude and significance. J Bone Miner Res 1994; 9: 1525–1532, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Weisinger J R, Alonzo E, Bellorin-Font E, Blasini A M, Rodriguez M A, Paz-Martinez V, Martinis R. Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int 1996; 49: 244–250, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ghazali A, Fuentes V, Desaint C, Bataille P, Westeel A, Brazier M, Prin L, Fournier A. Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab 1997; 82: 32–38, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Giannini S, Nobile M, Sartori L, Calò L, Tasca A, Dalle Carbonare L, Ciuffreda M, D'Angelo A, Pagano F, Crepaldi G. Bone density and skeletal metabolism are altered in idiopathic hypercalciuria. Clinical Nephrology 1998; 50: 94–100, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Misael d a Silva A M, dos Reis L M, Pereira R C, Futata E, Branco-Martins C T, Noronha I L, Wajchemberg B L, Jorgetti V. Bone involvement in idiopathic hypercalciuria. Clin Nephrol 2002; 57: 183–191, [CSA]
   Google Scholar
• Tasca A, Cacciola A, Ferrarese P, Ioverno E, Visona E, Bernardi C, Nobile M, Giannini S. Bone alterations in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Urology 2002; 59: 865–869, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Asplin J R, Bauer K A, Kinder J, Muller G, Coe B J, Parks J H, Coe F L. Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis. Kidney Int 2003; 63: 662–669, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Vezzoli G, Rubinacci A, Bianchin C, Arcidiacono T, Giambona S, Mignogna G, Fochesato E, Terranegra A, Cusi D, Soldati L. Intestinal calcium absorption is associated with bone mass in stone-forming women with idiopathic hypercalciuria. Am J Kidney Dis 2003; 42: 1177–1183, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Caudarella R, Vescini F, Buffa A. Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors. J Nephrol 2003; 16: 260–266, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Kanis J A. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 1994; 4: 368–381, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Melton L J, III, Crowson C S, Khosla S, Wilson D M, O'Fallon W M. Fracture risk among patients with urolithiasis: a population-based cohort study. Kidney Int 1998; 53: 459–464, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Lauderdale D S, Thisted R A, Wen M, Favus M J. Bone mineral Density and fracture among prevalent kidney stone cases in the Third National Health and Nutrition Examination Survey. J Bone Miner Res 2001; 16: 1893–1898, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Heilberg I P, Martini L A, Szejnfeld V L. Bone disease in calcium stone forming patients. Clin Nephrol 1994; 42: 175–182, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Bordier P, Rychewart A, Gueris J, Rasmussen H. On the pathogenesis of so-called idiopathic hypercalciuria. Am J Med 1977; 63: 398–409, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Steiniche T, Mosekilde L, Christensen M S, Melsen F. A histomorphometric determination of iliac bone remodeling in patients with recurrent renal stone formation and idiopathic hypercalciuria. Acta Pathol Microbiol Immunol Scand 1989; 97: 309–316
   Google Scholar
• Malluche H H, Tschoepe W, Ritz E, Meyer-Sabellek W, Massry S G. Abnormal bone histology in idiopathic hypercalciuria. J Clin Endocrinol Metab 1980; 50: 654–658, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Thomas J, Roujean J, Aboulker P. Les lésions osseuses dans la lithiase rénale. Leur étude par examen histologique d'un fragment costal. Presse Med 1962; 70: 2437–2440, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Zerwekh J E, Sakhaee K, Breslau N A, Gottschalk F, Pak C Y. Impaired bone formation in male idiopathic osteoporosis: further reduction in the presence of concomitant hypercalciuria. Osteoporos Int 1992; 2: 128–134, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Satton R AL, Walker V R. Bone resorption and hypercalciuria in calcium stone formers. Metabolism 1986; 35: 485–488, [CROSSREF]
   Google Scholar
• Barkin J, Wilson D R, Manuel M A, Bayley A, Murray T, Harrison J. Bone mineral content in idiopathic calcium nephrolithiasis. Miner Electrolyte Metab 1985; 11: 19–24, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Feskanich D, Willett W C, Stampfer M J, Colditz G A. A prospective study of thiazide use and fractures in women. Osteoporos Int 1997; 7: 79–84, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• LaCroix A Z, Wienpahl J, White L R, Wallace R B, Scherr P A, George L K, Cornoni-Huntley J, Ostfeld A M. Thiazide diuretic agents and the incidence of hip fracture. N Engl J Med 1990; 322: 286–290, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Nguyen T V, Eisman J A, Kelly P J, Sambrook P N. Risk factors for osteoporotic fractures in elderly men. Am J Epidemiol 1996; 144: 255–263, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Cauley J A, Cummings S R, Seeley D G, Black D, Browner W, Kuller L H, Nevitt M C. Effects of thiazide diuretic therapy on bone mass, fractures and falls. The Study of Osteoporotic Fractures Research Group. Ann Intern Med 1993; 118: 666–673, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Felson D T, Sloutskis D, Anderson J J, Anthony J M, Kiel D P. Thiazide diuretics and the risk of hip fracture. Results from the Framingham Study. JAMA 1991; 265: 370–373, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Schoofs M WJC, van der Klift M, Hofman A, de Laet C E, Herings R M, Stijnen T, Pols H A, Stricker B H. Thiazide diuretics and the risk for hip fracture. Ann Intern Med 2003; 139: 476–482, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Adams J S, Song C F, Kantorovich V. Rapid recovery of bone mass in hypercalciuric, osteoporotic man treated with hydrochlorothiazide. Ann Intern Med 1999; 130: 658–660, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Reid I R, Ames R W, Orr-Walker B J, Clearwater J M, Horne A M, Evans M C, Murray M A, McNeil A R, Gamble G D. Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial. Am J Med 2000; 109: 362–370, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• LaCroix A Z, Ott S M, Ichikawa L, Scholes D, Barlow W E. Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2000; 133: 516–526, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gowen M, Mundy G R. Actions of recombinant interleukin 1, interleukin 2 and interferon-gamma on bone resorption in vitro. J Immunol 1986; 136: 2478–2482, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Manolagas S C. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000; 21: 115–137, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Cohen-Solal M E, Graulet A M, Gueris J, Denne M A, Bergot C, Morieux C, Sedel L, Kuntz D, De Vernejoul M C. Bone resorption at the femoral neck is dependent on local factors in non osteoporotic late postmenopausal women: an in vivo-in vitro study. J Bone Miner Res 1995; 10: 307–315, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Chen W C, Wu H C, Chen H Y, Wu M C, Hsu C D, Tsai F J. Interleukin-1beta gene and receptor antagonist gene polymorphisms in patients with calcium oxalate stones. Urol Res 2001; 29: 321–324, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Giannini S, Nobile M, Sartori L, Dalle Carbonare L, Ciuffreda M, Corrò P, D'Angelo A, Calò L, Crepaldi G. Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Am J Clin Nutr 1999; 9: 267–271
   Google Scholar
• Maierhofer W J, Gray R W, Cheung H S, Lemann J, Jr. Bone resorption stimulated by elevated serum 1,25 (OH)2-vitamin D concentrations in healthy men. Kidney Int 1983; 24: 555–560, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Frick K K, Bushinsky D A. Molecular mechanisms of primary hypercalciuria. J Am Soc Nephrol 2003; 14: 1082–1095, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Fuss M, Pepersack T, Bergman P, Hurard T, Simon J, Corvilain J. Low calcium diet in idiopathic urolithiasis: a risk factor for osteopenia as great as in primary hyperparathyroidism. Br J Urol 1990; 65: 560–563, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Hess B. Low calcium diet in hypercalciuric calcium nephrolithiasis: first do not harm. Scanning Microsc 1996; 10: 547–554, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Curhan G C, Willett W C, Rimm E B, Stampfer M J. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993; 328: 833–838, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Williams C P, Child D F, Hudson P R, Soysa L D, Davies G K, Davies M G, De Bolla A R. Inappropriate phosphate excretion in idiopathic hypercalciuria: the key to a common cause and future treatment?. J Clin Pathol 1996; 49: 881–888, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Prié D, Ravery V, Boccon-Gibod L, Friedlander G. Frequency of renal phosphate leak among patients with calcium nephrolithiasis. Kidney Int 2001; 60: 272–276, [CROSSREF]
   Google Scholar
• Tieder M, Modai D, Shaked U, Samuel R, Arie R, Halabe A, Maor J, Weissgarten J, Averbukh Z, Cohen N, Edelstein S, Liberman U A. “Idiopathic” hypercalciuria and hereditary hypophosphatemic rickets. Two phenotypical expressions of a common genetic defect. N Engl J Med 1987; 316: 125–129, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Prié D, Huart V, Bakouh N, Planelles G, Dellis O, Gerard B, Hulin P, Benque-Blanchet F, Silve C, Grandchamp B, Friedlander G. Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter. N Engl J Med 2002; 347: 983–991, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Tannenbaum C, Clark J, Schwartzman K, Wallenstein S, Lapinski R, Meier D, Luckey M. Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab 2002; 87: 4431–4437, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Deutschmann H A, Weger M, Weger W, Kotanko P, Deutschmann M J, Skrabal F. Search for occult secondary osteoporosis: impact of identified possible risk factors on bone mineral density. J Intern Med 2002; 252: 389–397, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Peris P, Guanabens N, Martinez de Osaba M J, Monegal A, Alvarez L, Pons F, Ros I, Cerdà D, Munoz-Gomez J. Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish women. Semin Arthritis Rheum 2002; 32: 64–70, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Giannini S, Nobile M, Dalle Carbonare L, Lodetti M G, Sella S, Vittadello G, Minicuci N, Crepaldi G. Hypercalciuria is a common and important finding in postmenopausal women with osteoporosis. Eur J Endocrinol 2003; 149: 209–213, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Heshmati H M, Khosla S, Burritt M F, O'Fallon W M, Riggs B L. A defect in renal calcium conservation may contribute to the pathogenesis of postmenopausal osteoporosis. J Clin Endocrinol Metab 1998; 83: 1916–1920, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar